|
[1]TORRE LA, BRAY F, SIEGEL RL, et al.Global cancer statistic, 2012[J].Ca A Cancer J Clin, 2015, 65 (2) :87-108.
|
|
[2]CHEN W, ZHENG R, BAADE PD, et al.Cancer statistics in China, 2015[J].Ca A Cancer J Clin, 2016, 66 (2) :115-133.
|
|
[3]AMERES SL, ZAMORE PD.Diversifying microRNA sequence and function[J].Nat Rev Mol Cell Biol, 2013, 14 (8) :475-488.
|
|
[4]CHEN PY, MANNINGA H, SLANCHEV K, et al.The developmental miRNA profiles of zebrafish as determined by small RNA cloning[J].Genes Dev, 2005, 19 (11) :1288-1293.
|
|
[5]ROUSH S, SLACK FJ.The let-7, family of microRNAs[J].Trends Cell Bio, 2008, 18 (10) :505-516.
|
|
[6]SHELL S, PARK SM, RADJABI AR, et al.Let-7 expression defines two differentiation stages of cancer[J].Proc Natl Acad Sci US A, 2007, 104 (27) :11400-11405.
|
|
[7]LI L, CHEN J, CHEN X, et al.Serum miRNAs as predictive and preventive biomarker for pre-clinical hepatocellular carcinoma[J].Cancer Lett, 2016, 373 (2) :234-240.
|
|
[8]HUNG C, HU T, LU S, et al.Circulating microRNAs as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis B virus[J].Int J Cancer, 2015, 138 (3) :714-720.
|
|
[9]LIU XB, ZOU HL, YU DK, et al.Serum expression of let-7a and let-7f and its clinical significance in patients with hepatocellular carcinoma[J].Chin Hepatol, 2015, 20 (9) :733-735. (in Chinese) 刘旭斌, 邹汉良, 余德奎, 等.肝细胞癌患者血清let-7a、let-7f表达水平及其临床意义[J].肝脏, 2015, 20 (9) :733-735.
|
|
[10]Mc DANIEL K, HAL C, SATO K, et al.Lin28 and let-7:roles and regulation in liver diseases[J].Am J Physiol Gastrointest Liver Physiol, 2016, 310 (10) :757-765.
|
|
[11]GANG W, HUANG P, JU X, et al.Lin28B over-expression mediates the repression of let-7 by hepatitis B virus X protein in hepatoma cells[J].Int J Clin Exp Med, 2015, 8 (9) :15108-15116.
|
|
[12]KIM SK, LEE H, HAN K, et al.SET7/9 methylation of the pluripotency factor LIN28A is a nucleolar localization mechanism that blocks let-7 biogenesis in human ESCs[J].Cell Stem Cell, 2014, 15 (6) :735-749.
|
|
[13]DENG L, YANG S, XU F, et al.Long noncoding RNA CCAT1promotes hepatocellular carcinoma progression by functioning as let-7 sponge[J].J Exp Clin Cancer Res, 2015, 34 (1) :1-10.
|
|
[14]HE X, TAN X, WANG X, et al.C-Myc-activated long noncoding RNA CCAT1 promotes colon cancer cell proliferation and invasion[J].Tumour Biol, 2014, 35 (12) :12181-12188.
|
|
[15]YANG F, XUE X, BI J, et al.Long noncoding RNA CCAT1, which could be activated by c-Myc, promotes the progression of gastric carcinoma[J].J Cancer Res Clin Oncol, 2013, 34 (1) :18-28.
|
|
[16]SHEN T, HUANG S.The role of Cdc25A in the regulation of cell proliferation and apoptosis[J].Anticancer Agents Med Chem, 2012, 12 (6) :631-639.
|
|
[17]LANDRIEU I, DA CM, DE VL, et al.A small CDC25 dual-specificity tyrosine-phosphatase isoform in Arabidopsis thaliana[J].Proc Natl Acad Sci U S A, 2004, 101 (36) :13380-13385.
|
|
[18]KRISTJANSDOTTIR K, RUDOLPH J.Cdc25 phosphatases and cancer[J].Chem Biol, 2004, 11 (8) :1043-1051.
|
|
[19]KANG TB, WEI YK, HONAKER YC, et al.GSK-3βtargets CDC25A for ubiquitin-mediated proteolysis, and GSK-3βinactivation correlates with CDC25A overproduction in human cancers[J].Cancer Cell, 2008, 13 (1) :36-47.
|
|
[20]XU X, YAMAMOTO H, LIU G, et al.CDC25A inhibition suppresses the growth and invasion of human hepatocellular carcinoma cells[J].Int J Mol Med, 2008, 21 (2) :145-152.
|
|
[21] GONG FX, SUN RH, XIA JL, et al.MicroRNA let-7c inhibits proliferation of hepatocellular carcinoma cells by targeting cyclindependent kinase 6[J].Chin J Exp Surg, 2016, 33 (12) :2698-2701. (in Chinese) 公方晓, 孙仁华, 夏景林, 等.微小RNA let-7c通过靶定细胞周期蛋白依赖激酶6抑制肝癌细胞增殖[J].中华实验外科杂志, 2016, 33 (12) :2698-2701.
|
|
[22]ZHU X, WU L, YAO J, et al.MicroRNA let-7c inhibits cell proliferation and induces cell cycle arrest by targeting CDC25A in human hepatocellular carcinoma[J].PLo S One, 2015, 10 (4) :e0124266.
|
|
[23]LAN FF, WANG H, CHEN YC, et al.Hsa-let-7g inhibits proliferation of hepatocellular carcinoma cells by downregulation of cMyc and upregulation of p16INK4A[J].Int J Cancer, 2011, 128 (2) :319-331.
|
|
[24]SILVA J, GARCIA JM, PENA C, et al.Implication of polycomb members Bmi-1, Mel-18, and Hpc-2 in the regulation of p16INK4a, p14ARF, h-TERT, and c-Myc expression in primary breast carcinomas[J].Clin Cancer Res, 2007, 12 (23) :6929-6936.
|
|
[25]YONG SL, DUTTA A.The tumor suppressor microRNA let-7 represses the HMGA2 oncogene[J].Genes Dev, 2007, 21 (9) :1025-1030.
|
|
[26]WU LL.The study on the role and mechanism of let-7g inhibiting HCC proliferation and invasion by downregulation of HMA2[D].Central South University, 2013. (in Chinese) 伍列林.Let-7g下调HMGA2抑制原发性肝细胞癌增殖、侵袭的作用及机制研究[D].中南大学, 2013.
|
|
[27]TAKATA A, OTSUKA M, OHNO M, et al.Mutual antagonism between hepatitis B viral mRNA and host microRNA let-7[J].Sci Rep, 2016, 6:23237-23246.
|
|
[28]JI JF, ZHAO L, BUDHU A, et al.Let-7g targets collagen type Ialpha2 and inhibits cell migration in hepatocellular carcinoma[J].JHepatol, 2010, 52 (5) :690-697.
|
|
[29]FAWZY IO, HAMZA MT, HOSNY KA, et al.MiR-1275:a single microRNA that targets the three IGF2-mRNA-binding proteins hindering tumor growth in hepatocellular carcinoma[J].Febs Lett, 2015, 589 (17) :2257-2265.
|
|
[30]FAWZY IO, HAMZA MT, HNSNY KA, et al.Abrogating the interplay between IGF2BP1, 2 and 3 and IGF1R by let-7i arrests hepatocellular carcinoma growth[J].Growth Factors, 2016, 34 (1-2) :42-50.
|
|
[31]KESSLER SM, POKORNY J, ZIMMER V, et al.IGF2 mRNAbinding protein p62/IMP2-2 in hepatocellular carcinoma:antiapoptotic action is independent of IGF2/PI3K signaling[J].Am JPhysiol Gastrointest Liver Physiol, 2012, 304 (4) :328-336.
|
|
[32]GUTSCHNER T, HAMMERLE M, PAZAITIS N, et al.Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is an important protumorigenic factor in hepatocellular carcinoma.[J].Hepatology, 2014, 59 (5) :1900-1911.
|
|
[33]NOUBISSI FK, NIKIFOROV MA, COLBURN N, et al.Transcriptional regulation of CRD-BP by c-myc:implications for c-myc functions[J].Genes Cancer, 2010, 1 (10) :1074-1082.
|
|
[34]SHIMIZU S, TAKEHARA T, HIKITA H, et al.The let-7 family of microRNAs inhibits Bcl-x L expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma[J].J Hepatol, 2010, 52 (5) :698-704.
|
|
[35]MA J, GUO R, WANG T, et al.Let-7b binding site polymorphism in the B-cell lymphoma-extra large 3'UTR is associated with fluorouracil resistance of hepatocellular carcinoma[J].Mo Med Rep, 2014, 11 (1) :677-681.
|
|
[36]YUAN Y.The mechanism of let-7c mediated c-Myc gene regulation reversing the multidrug resistance of hepatocellular carcinoma cells[D].Lanzhou University, 2015. (in Chinese) 袁媛.let-7c介导c-Myc基因调控逆转肝癌细胞多药耐药的机制研究[D].兰州大学, 2015.
|
|
[37]LIU L, LU L, ZHENG A, et al.MiR-199a-5p and let-7c cooperatively inhibit migration and invasion by targeting MAP4K3 in hepatocellular carcinoma[J].Oncotarget, 2017, 8 (8) :13666-13677.
|
DownLoad: